Vaxart, Inc.

Vaxart, Inc.verified

VXRT

Price:

$0.37

Market Cap:

$88.82M

Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1 and GII.4 norovirus strains; seasonal influenza vaccine, which is in Phase II clinical trial for the treatment of H1 influenza infection; respiratory syncytial virus vaccine; and coronavirus vaccine, which is in Phase II clinical trial for the treatment of SARS-CoV-2 infection. It is also developing therapeutic vaccines for cervical cancer and dyspla...[Read more]

Industry

Biotechnology

IPO Date

1981-12-11

Stock Exchange

NASDAQ

Ticker

VXRT

The Enterprise Value as of December 2025 (TTM) for Vaxart, Inc. (VXRT) is 87.39M

According to Vaxart, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 87.39M. This represents a change of -15.51% compared to the average of 103.42M of the last 4 quarters.

Vaxart, Inc. (VXRT) Historical Enterprise Value (quarterly & annually)

How has VXRT Enterprise Value performed in the past?

The mean historical Enterprise Value of Vaxart, Inc. over the last ten years is 782.82M. The current 87.39M Enterprise Value has changed 1.02% with respect to the historical average. Over the past ten years (40 quarters), VXRT's Enterprise Value was at its highest in in the June 2020 quarter at 6.57B. The Enterprise Value was at its lowest in in the September 2019 quarter at 43.91M.

Quarterly (TTM)
Annual

Average

782.82M

Median

295.77M

Minimum

64.28M

Maximum

2.94B

Vaxart, Inc. (VXRT) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Vaxart, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 4.07%

Maximum Annual Enterprise Value = 2.94B

Minimum Annual Increase = -84.63%

Minimum Annual Enterprise Value = 64.28M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2024320.67M18.39%
2023270.86M-39.97%
2022451.18M-84.63%
20212.94B9.65%
20202.68B4.07%
201964.28M-42.04%
2018110.90M-57.91%
2017263.48M9.09%
2017241.52M-50.90%
2016491.90M-28.53%

Vaxart, Inc. (VXRT) Average Enterprise Value

How has VXRT Enterprise Value performed in the past?

The current Enterprise Value of Vaxart, Inc. (VXRT) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

347.57M

5-year avg

1.33B

10-year avg

782.82M

Vaxart, Inc. (VXRT) Enterprise Value vs. Peers

How is VXRT’s Enterprise Value compared to its peers?

Vaxart, Inc.’s Enterprise Value is greater than Acrivon Therapeutics, Inc. Common Stock (43.63M), greater than Unicycive Therapeutics, Inc. (72.37M), greater than CAMP4 Therapeutics Corporation (40.08M), greater than Immunic, Inc. (32.92M), greater than PMV Pharmaceuticals, Inc. (25.00M), less than Relmada Therapeutics, Inc. (291.98M), less than Cibus, Inc. (94.92M), greater than TScan Therapeutics, Inc. (-43127305.00), greater than Repare Therapeutics Inc. (23.36M), greater than Fortress Biotech, Inc. (67.42M),

Build a custom stock screener for Vaxart, Inc. (VXRT) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Vaxart, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Vaxart, Inc. (VXRT) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Vaxart, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Vaxart, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Vaxart, Inc. (VXRT)?

What is the 3-year average Enterprise Value for Vaxart, Inc. (VXRT)?

What is the 5-year average Enterprise Value for Vaxart, Inc. (VXRT)?

How does the current Enterprise Value for Vaxart, Inc. (VXRT) compare to its historical average?